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Blastomyces: Why Be Dimorphic?
Dennis J. Baumgardner, MD │ Message from the Editor-in-Chief
Department of Family Medicine, Aurora University of Wisconsin Medical Group, Aurora Health Care, Milwaukee, WI

Greetings and welcome to our special issue dedicated
to the study of infectious diseases. This subject is
especially near and dear to my heart since, a long time
ago in a galaxy far far away, I studied microbiology
prior to becoming a physician –– and, shockingly, I
continue to put this undergraduate degree to use some
40 years later. You may notice two of the articles in this
issue wholly or partly deal with the environmentally
acquired fungal disease blastomycosis.1,2 While not
claiming to be an expert, this disease and the organisms
involved have kept me fascinated and engaged for
more than 25 years.
Blastomycosis was first described in the late 1800s,
with a high proportion of recognized cases confined
to the skin.3 We now recognize that almost all cases
occur following inhalation of conidia (spores) from the
environmental source into the lungs. The pulmonary
infection that may follow is often asymptomatic, but
can range from mild to severe to life-threatening. The
fungus may disseminate from the lungs and cause
disease in a variety of organs and tissues, including
the skin.4 The etiologic agents of blastomycosis are
now considered members of one of two species,
Blastomyces dermatitidis or Blastomyces gilchristii.5
But at least two central mysteries pertaining to
Blastomyces persist.
One of the mysteries, as discussed in this issue by
Huber et al., is that the particular environmental
niche of Blastomyces, if there is a specific one, is still
being elucidated.1 These organisms are dimorphic
microscopic fungi. What does that mean? Simply put,
they are microbial “switch-hitters” that grow as a mold
at normal environmental temperatures, then undergo
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a complex phase transition
and grow as a broad-based,
budding yeast at body
temperature (and under
certain other conditions).4,6-8
The second mystery yet to
be solved is exactly why
these organisms evolved this
dimorphic ability and devote
so much genetic and cellular
machinery to the phase transition. Clearly, a transition
to yeast at body temperature allows the fungus to
successfully infect and propagate within a mammal
–– outside of the laboratory, this occurs predominantly
in dogs, humans and an occasional domesticated cat.
The resultant yeast cell is too large to be ingested by
polymorphonuclear neutrophils (PMNs), unlike the
smaller infectious conidia particles (spores). The yeast
is also less readily killed by PMNs and peripheral
blood monocytes.6 Recent experiments in mice suggest
that ingestion of spores by alveolar macrophages,
conversion of the spores to yeast and a transient
intracellular residence in these macrophages may be
important for early successful pulmonary infection.9
But what does successful infection of the known
susceptible humans and animals do for the long-term
success of Blastomyces as a competitive environmental
species? Is there any other possible reason for this
(predominantly) thermal dimorphism? Such knowledge
gaps beg for speculation among scientists (and much
of the remainder of this commentary is just that).
At least in the modern era, humans and domesticated
mammals are considered dead-end hosts for
Blastomyces.3 There is virtually no person-to-person
or animal-to-person spread. While genomic analysis
suggests that another dimorphic fungus, Coccidioides
(endemic to southwest North America and portions of
Central and South America), resides in mammalian
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host carcasses within soil rather than the soil itself,10
the contribution of mammalian host carcasses in the
natural environment to propagation of Blastomyces is
unknown. No significant animal natural host or vector
has yet been identified.11 This differs from a related
dimorphic fungus, Paracoccidioides brasiliensis,
which has been shown to have a natural mammalian
host, the armadillo, that may have afforded a
long coexistence with the fungus.12 Bagagli et al.
hypothesized that parasitism (yeast-form colonization/
infection of a warm-blooded animal) helps the
Paracoccidioides fungus “find shelter, food and
opportunities for multiplication and dispersal,” thereby
increasing the opportunity for sexual reproduction to
minimize genetic weakness.12
It is certainly conceivable that Blastomyces could be
spread to the natural environment from a person or
animal with fulminating pulmonary blastomycosis via
expectorated sputum or saliva containing significant
yeast forms of the organism.13 Saliva, in fact, may help
protect yeast-phase Blastomyces from lysis by bacteria
on natural substances.14 Blastomyces also has been
identified in mammalian stool, including human,15
dog16 and, via experimental oral inoculation, bat.17
Neither Blastomyces nor a related dimorphic fungus,
Histoplasma capsulatum, have been isolated from the
cloaca of birds; however, the latter has been strongly
associated with bird guano.18 Could temporary or more
permanent colonization of the gastrointestinal tract of
a known host or a previously unrecognized associated
animal be common enough to qualify as important for
the dispersal of Blastomyces? The transient passage of
fungal forms in feces of those animals with fulminating
pulmonary infection would presumably be rare, but
perhaps frequent enough for effective dispersal,
especially in centuries prior to modern sanitation
(Blastomyces and relatives likely date back several
million years12). Could inadvertent swallowing of
mold forms of the fungus and colonic passage of mold
or yeast forms by animals that feed or peck among soil
offer a more common form of dispersal? Blastomyces
strains have been shown to grow in vitro when exposed
to ammonia levels up to 42–62 mmol/l in the mold
form19 and at least 21 mmol/l in the yeast form (Dennis
Baumgardner, unpublished observations). This may
be critical, given elevated ammonia concentrations in
excreta of birds,20 the large intestine of rodents21 and
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human colons in which levels up to 60–70 mmol/l may
be transiently reached.22
As we have previously discussed,23 at least one
Blastomyces strain (ER-3/ATCC MYA 2586) appears
to be nonpathogenic in the laboratory (Bruce Klein,
personal communication; and as reported by the Broad
Institute24). However, this strain readily converts to the
yeast form at 37°C on standard media and, to some
extent, at room temperature under certain nutritional
conditions.8 If there are indeed strains that are
inherently nonpathogenic in the environment, it makes
the mystery even more intriguing –– for example, the
purpose could be to colonize (if even transiently), but
not infect, mammalian surfaces or the gastrointestinal
tract for purposes of dispersal. This possibility was
investigated in two groups of animals that yielded
negative results. Cultures of the intestinal tracts of 60
shrews and 5 small rodents as well as rectal cultures
from several beavers failed to grow Blastomyces.11,25
Perhaps thermal dimorphism was critical millions
of years ago when warm water environments were
frequently encountered and the yeast form afforded
some sort of advantage over conidia for water
dispersion. We simply do not know.
How then did strains of Blastomyces become
pathogenic for animals in the first place? As proposed
by Casadevall and colleagues26-28 and reiterated by
Bagagli et al.,12 virulence factors of soil-dwelling
fungi may have evolved to ward off destruction by
nematodes or amoebae, and may have already been in
place to survive in mammalian hosts once appropriate
mammals evolved. Whereas most of these organisms
are restricted from infection by the higher mammalian
body temperature,28 not so when it comes to dimorphic
fungi.
All things considered, it seems plausible that
Blastomyces evolved thermal dimorphism for a
necessary, but more benign, purpose than infecting and
potentially killing us or our companion animals.
Finally, it is no secret we at the Journal of PatientCentered Research and Reviews pride ourselves on
publishing patient-based content. Heck, it’s right there
in our name. So you may be wondering what possible
benefit this intellectual discourse adds to the care of the
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patient. As one who has spoken to scores of patients
with blastomycosis and their family members, I will
testify that people want to know “where this disease
comes from,” including details of why it lives in
a certain environment and how it gets into people.
Perhaps this editorial will inform these discussions.
Ultimately, further research into the whys and hows
of blastomycosis pathogenesis may lead to improved
treatment.
Besides, isn’t science fun?
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